Skip to content
healthcare.dev

Acetazolamide

NDC 81005-105, Acetazolamide, tablet, from Aarkish Pharmaceuticals NJ Inc..

Product NDC
81005-105
Status
Listed
Labeler
Aarkish Pharmaceuticals NJ Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217197
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/81005-105 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACETAZOLAMIDE250 mg/1

Pharmacologic classes

Carbonic Anhydrase Inhibitor [EPC]; Carbonic Anhydrase Inhibitors [MoA]; Sulfonamides [CS]

Package NDCNDC-11Package
81005-105-0181005010501100 TABLET in 1 BOTTLE (81005-105-01)
81005-105-10810050105101000 TABLET in 1 BOTTLE (81005-105-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ddfd44dc-3136-4dda-8ed0-eb2991c2a0b6

Use it

Look up 81005-105 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/81005-105 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 81005-105. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.